Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity

Annals of Neurology

Volumn 75, Issue 5, 2014, Pages 739-758

  Breuer, Johanna ^a   Schwab, Nicholas ^a   Schneider Hohendorf, Tilman ^a   Marziniak, Martin ^a,e   Mohan, Hema ^a   Bhatia, Urvashi ^a   Gross, Catharina C ^a   Clausen, Björn E ^b   Weishaupt, Carsten ^a   Luger, Thomas A ^a,c,d   Meuth, Sven G ^a,c,d   Loser, Karin ^a,c,d   Wiendl, Heinz ^a,c,d  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Interdisciplinary Center of Clinical Research   (Germany)

^d Interdisciplinary Center of Clinical Research ^*  (Germany)

^e Isar Amper Clinics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; INTERLEUKIN 21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; LANGERHANS CELL; LYMPH NODE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; ULTRAVIOLET B RADIATION;

ADULT; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; T-LYMPHOCYTES, REGULATORY; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; YOUNG ADULT;

EID: 84902206179     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24165     Document Type: Article

References (48)

1. Koch MW, Metz LM, Agrawal SM, Yong VW,. Environmental factors and their regulation of immunity in multiple sclerosis. J Neurol Sci 2013; 324: 10-16.
2. Wahren-Herlenius M, Dörner T,. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013; 382: 819-831.
3. Sospedra M, Martin R,. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683-747.
4. Simpson S, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82: 1132-1141.
5. Hart PH, Gorman S, Finlay-Jones JJ,. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011; 11: 584-596.
6. van der Mei IAF, Simpson S, Stankovich J, Taylor BV,. Individual and joint action of environmental factors and risk of MS. Neurol Clin 2011; 29: 233-255.
7. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838.
8. Mowry EM, Waubant E, McCulloch CE, et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 2012; 72: 234-240.
9. Raghuwanshi A, Joshi SS, Christakos S,. Vitamin D and multiple sclerosis. J Cell Biochem 2008; 105: 338-343.
10. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776.
11. Loser K, Mehling A, Loeser S, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006; 12: 1372-1379.
12. Schwarz A, Noordegraaf M, Maeda A, et al. Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol 2010; 130: 1419-1427.
13. Zozulya AL, Wiendl H,. The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 384-398.
14. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA,. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
15. Anderton SM, Liblau RS,. Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr Opin Neurol 2008; 21: 248-254.
16. Feger U, Luther C, Poeschel S, et al. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 2007; 147: 412-418.
17. Bennett CL, van Rijn E, Jung S, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169: 569-576.
18. Göbel K, Pankratz S, Schneider-Hohendorf T, et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J Autoimmun 2011; 36: 106-114.
19. Cravens PD, Hussain RZ, Zacharias TE, et al. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. J Neuroinflammation 2011; 8: 73.
20. Auriemma M, Brzoska T, Klenner L, et al. α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation. J Invest Dermatol 2012; 132: 1814-1824.
21. Schneider-Hohendorf T, Stenner M-P, Weidenfeller C, et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40: 3581-3590.
22. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
23. Johnson-Huang LM, Suárez-Fariñas M, Sullivan-Whalen M, et al. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol 2010; 130: 2654-2663.
24. Schwab N, Zozulya AL, Kieseier BC, et al. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J Immunol 2010; 184: 5368-5374.
25. Zabransky DJ, Nirschl CJ, Durham NM, et al. Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE 2012; 7: e34547.
26. Read S, Malmström V, Powrie F,. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
27. Schwarz A, Beissert S, Grosse-Heitmeyer K, et al. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J Immunol 2000; 165: 1824-1831.
28. Adler HS, Steinbrink K,. Tolerogenic dendritic cells in health and disease: friend and foe. Eur J Dermatol 2007; 17: 476-491.
29. Mahnke K, Johnson TS, Ring S, Enk AH,. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 2007; 46: 159-167.
30. Borkowski TA, Nelson AJ, Farr AG, Udey MC,. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur J Immunol 1996; 26: 110-114.
31. Su H, Cong X, Liu YL,. Transplantation of granulocytic myeloid-derived suppressor cells (G-MDSCs) could reduce colitis in experimental murine models. J Dig Dis 2013; 14: 251-258.
32. Zindl CL, Lai J-F, Lee YK, et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A 2013; 110: 12768-12773.
33. Lapolla W, Yentzer BA, Bagel J, et al. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol 2011; 64: 936-949.
34. Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010; 184: 3433-3441.
35. Korn T, Bettelli E, Oukka M, Kuchroo VK,. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
36. Farias AS, Spagnol GS, Bordeaux-Rego P, et al. Vitamin D3 induces IDO(+) tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci Ther 2013; 19: 269-277.
37. Lucas RM, Ponsonby A-L, Dear K, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76: 540-548.
38. Becklund BR, Severson KS, Vang SV, DeLuca HF,. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci U S A 2010; 107: 6418-6423.
39. Juryńczyk M, Walczak A, Jurewicz A, et al. Immune regulation of multiple sclerosis by transdermally applied myelin peptides. Ann Neurol 2010; 68: 593-601.
40. Walczak A, Siger M, Ciach A, et al. Transdermal application of myelin peptides in multiple sclerosis treatment. JAMA Neurol 2013; 70: 1105-1109.
41. Schwarz A, Maeda A, Wild MK, et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 2004; 172: 1036-1043.
42. Odoardi F, Sie C, Streyl K, et al. T cells become licensed in the lung to enter the central nervous system. Nature 2012; 488: 675-679.
43. Himmel ME, MacDonald KG, Garcia RV, et al. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J Immunol 2013; 190: 2001-2008.
44. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448: 484-487.
45. Attridge K, Wang CJ, Wardzinski L, et al. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 2012; 119: 4656-4664.
46. Roncarolo MG, Battaglia M,. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7: 585-598.
47. Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71: 306-314.
48. Soontrapa K, Honda T, Sakata D, et al. Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc Natl Acad Sci U S A 2011; 108: 6668-6673.